High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS : Figure 2

Figure 2: Kaplan-Meier curve showing the effects of hsTnT levels on adverse events following in non-STEACS patients. Patients with raised hs TnT levels, had a significant worse outcome compared with patients with lower hsTnT levels at 12-month followup (cutoff point >0.0013 ng/mL; log-rank test, ).